Loading company…
Riskpilot
← Back to search
Sign in
Get full access
SCIENCONS AS
AS
Active
Org 913262123
Kjelsåsveien 168, 0884 Oslo
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2014
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
+3% vs 2023
Equity ratio
87.5%
Financial strength
Net profit 2024
NOK 1,3M
-89% vs 2023
EBITDA — year on year
NOK millions
3M
2M
1M
-0M
-1M
0M
2020
-1M
-100%
2021
2M
+300%
2022
-1M
-150%
2023
0M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -495K
+3%
Net profit
NOK 1,3M
-89%
Total assets
NOK 53M
+2%
Equity
NOK 46,4M
+3%
Employees
0
—
Company information
Legal name
SCIENCONS AS
Org number
913262123
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11. mars 2014
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investeringer i andre selskaper, oppfinnervirksomhet og ytelse av konsulenttjenester samt det som naturlig står i forbindelse med dette.
Contact
Address
Kjelsåsveien 168, 0884 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
1M
1M
2M
2M
0M
2020
0M
2021
2M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
1M
1M
2M
2M
0M
2020
-1M
2021
2M
2022
-1M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
114
69
2 458
7
0
Staff expenses
−31
−43
−40
−39
−39
EBITDA
−325
−669
1 744
−510
−495
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−325
−669
1 744
−510
−495
Net financials
542
4 571
−166
12 204
1 837
Profit before tax
217
3 902
1 578
11 693
1 342
Tax
−0
−0
−0
−0
−0
Net profit
217
3 902
1 578
11 693
1 342
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
34 547
38 477
40 665
51 940
53 034
Equity
27 892
31 794
33 371
45 064
46 406
Long-term debt
6 628
6 628
6 632
6 632
6 632
Short-term debt
27
55
661
244
−4
Total debt
6 656
6 684
7 293
6 875
6 628
Financial ratios
5-year trend
EBITDA margin
-49493600.0%
This company
15.8%
Market median
-313250733% vs market
2020
2024
Equity ratio
87.5%
This company
38.2%
Market median
+129% vs market
2020
2024
Return on equity
2.9%
This company
18.4%
Market median
-84% vs market
2020
2024
Net profit margin
134188600.0%
This company
8.1%
Market median
+1656649283% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
RH
Roy Hartvig Larsen
Chairman
2014
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
SCIENCONS AS
(this company)
SRB RADIOPHARMA HOLDING AS
ONCOINVENT ASA
Board network connections
Board members of SCIENCONS AS also hold positions in
0
other companies.
Person
Role here
Other companies
Roy Hartvig Larsen
Chairman
0 companies